Drugs / peripheral blood progenitor cells carrying MDR1
peripheral blood progenitor cells carrying MDR1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001493 | Oct 1995 → Jun 2000 | breast neoplasm, metastatic neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | peripheral blood progenitor cells carrying MDR1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001493 ↗ |
| Modality | Cell therapy | “This pilot trial will determine whether retroviral-transduced peripheral blood progenitor cells (PBPCs) can be selected and expanded in vivo after non-ablative chemotherapy in...” NCT00001493 ↗ |